Raymond James Financial Inc. Grows Holdings in ARK Genomic Revolution ETF $ARKG

Raymond James Financial Inc. grew its holdings in shares of ARK Genomic Revolution ETF (BATS:ARKG) by 65.4% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 142,362 shares of the company’s stock after buying an additional 56,283 shares during the quarter. Raymond James Financial Inc. owned 0.31% of ARK Genomic Revolution ETF worth $2,955,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in ARKG. Balyasny Asset Management L.P. purchased a new position in shares of ARK Genomic Revolution ETF during the 4th quarter valued at approximately $2,424,000. Baird Financial Group Inc. boosted its stake in shares of ARK Genomic Revolution ETF by 21.1% during the 4th quarter. Baird Financial Group Inc. now owns 10,127 shares of the company’s stock valued at $238,000 after buying an additional 1,765 shares during the last quarter. Hudson Bay Capital Management LP boosted its stake in shares of ARK Genomic Revolution ETF by 3.3% during the 4th quarter. Hudson Bay Capital Management LP now owns 155,000 shares of the company’s stock valued at $3,649,000 after buying an additional 5,000 shares during the last quarter. Sig Brokerage LP purchased a new position in shares of ARK Genomic Revolution ETF during the 4th quarter valued at approximately $954,000. Finally, Two Sigma Investments LP boosted its stake in shares of ARK Genomic Revolution ETF by 626.8% during the 4th quarter. Two Sigma Investments LP now owns 961,500 shares of the company’s stock valued at $22,639,000 after buying an additional 829,200 shares during the last quarter.

ARK Genomic Revolution ETF Price Performance

ARKG stock opened at $25.51 on Monday. ARK Genomic Revolution ETF has a 12-month low of $17.51 and a 12-month high of $31.16. The stock’s 50 day simple moving average is $24.78 and its 200 day simple moving average is $23.24.

ARK Genomic Revolution ETF Company Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.